Hygromycin B Pulver 500 mg
Zellbiologie
Hygromycin B Powder 500 mg
|
O-6-Amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1-2-3)-O-beta-D-talopyranosyl-(1-5)-2-deoxy-N3-methyl-D-streptamine. Aminoglycoside antibiotic. | |
|
Aminoglycoside antibiotic that inhibits growth of procaryotic micro-organisms (bacteria), eukaryotic micro-organisms (yeast) and mammalian cells. Inhibits protein synthesis at translocation step: causes misreading of mRNA. A gene from E.coli encoding resistance to hygromycin B can be isolated and cloned by recombinant DNA technology. It is useful for the identification or selection of recombinant clones in various cell types. The working concentration for mammalian cell selection is normally between 50µg/mL and 1mg/mL, plant cells: 20µg/mL-200µg/mL, bacteria: 20µg/mL-200µg/mL and Fungi: 200µg/mL - 1mg/mL. The appropriate concentration should be tested experimentally. |
Hygromycin B Powder 500 mg - M3125.0500 |
Documentation:
Hygromycin B Powder 500 mg
Productnumber: M3125.0500
Productdetails:
Hygromycin B Powder 500 mg
Manualcertificate:
Hygromycin B Powder 500 mg
Technical Data: min. 90%; specific activity: 1x10(6) U/g; substance is soluble in water; C20H37N3O13; MW = 527.53 g/mol; CAS [31282-04-9]; toxic/harmful; may be cancerogenic or teratogenic; working solutions (<2mg/mL) are stable for about 1 month at +4°C, it is recommended to use end concentrations between 100µg/mL and 800µg/mL.
Shipping/Storing-Information: shipped and stored at RT
Matchcode: aminoglycoside misreading of mRNA hygromycin
